RightFit Trial Directory

Prostate Cancer clinical trials in Houston, TX

84 recruiting prostate cancer studies with a site in Houston, TX.

All trials in Houston, TX · All Prostate Cancer trials

RecruitingPhase 3NCT06136650

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

Sponsor: Merck Sharp & Dohme LLC

Austin, TX · Dallas, TX · +60 more sites

RecruitingPhase 3NCT07213674

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Sponsor: Amgen

Arlington, TX · Dallas, TX · Houston, TX · +43 more sites

RecruitingPhase 2NCT05873192

Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 3NCT07611110

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

Sponsor: AstraZeneca

Houston, TX · +27 more sites

RecruitingPhase 1NCT06465069

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Sponsor: Eli Lilly and Company

Houston, TX · San Antonio, TX · +21 more sites

RecruitingPhase 3NCT07365995

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Sponsor: BioNTech SE

Austin, TX · Houston, TX · Tyler, TX · +18 more sites

RecruitingPhase 1 / Phase 2NCT06239194

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Sponsor: ModeX Therapeutics, An OPKO Health Company

Houston, TX · San Antonio, TX · +4 more sites

RecruitingPhase 2NCT05691465

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

Sponsor: National Cancer Institute (NCI)

Dallas, TX · Houston, TX · +11 more sites

RecruitingPhase 1 / Phase 2NCT07590934

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Sponsor: AstraZeneca

Houston, TX · +11 more sites

RecruitingNot applicableNCT06511141

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Sponsor: Axonics, Inc.

Arlington, TX · Houston, TX · +21 more sites

RecruitingPhase 3NCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Sponsor: SWOG Cancer Research Network

Conroe, TX · Dallas, TX · +331 more sites

RecruitingPhase not listedNCT05497024

Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Sponsor: Parabilis Medicines, Inc.

Houston, TX · San Antonio, TX · +29 more sites

RecruitingPhase 1NCT05997615

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Sponsor: Astellas Pharma Global Development, Inc.

Houston, TX · +7 more sites

RecruitingPhase 1NCT07114601

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Sponsor: Eli Lilly and Company

Dallas, TX · Houston, TX · +14 more sites

RecruitingPhase 3NCT07723248

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Sponsor: ORIC Pharmaceuticals

Dallas, TX · Fort Worth, TX · Houston, TX · +8 more sites

RecruitingPhase 1 / Phase 2NCT04585750

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Sponsor: PMV Pharmaceuticals, Inc

Austin, TX · Bedford, TX · Dallas, TX · +29 more sites

RecruitingPhase not listedNCT05334069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Sponsor: Alliance for Clinical Trials in Oncology

Amarillo, TX · Bryan, TX · Houston, TX · +744 more sites

RecruitingPhase 2NCT06172478

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Sponsor: Daiichi Sankyo

Houston, TX · +12 more sites

RecruitingPhase 1 / Phase 2NCT07189871

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Sponsor: Radiopharm Theranostics, Ltd

Houston, TX · +4 more sites

RecruitingPhase 1NCT06095089

A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer

Sponsor: Janssen Research & Development, LLC

Houston, TX · San Antonio, TX · +10 more sites

RecruitingNot applicableNCT06496256

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

Sponsor: Palette Life Sciences, Inc.

Austin, TX · Houston, TX · +9 more sites

RecruitingPhase 1 / Phase 2NCT07594106

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Sponsor: Regeneron Pharmaceuticals

Houston, TX · +5 more sites

RecruitingEarly Phase 1NCT06759701

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1 / Phase 2NCT06800313

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Sponsor: Janssen Research & Development, LLC

Austin, TX · Houston, TX · +15 more sites

RecruitingPhase 3NCT07164443

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Sponsor: Janssen Research & Development, LLC

Dallas, TX · Houston, TX · +51 more sites

RecruitingPhase 1 / Phase 2NCT07181161

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Sponsor: AstraZeneca

Houston, TX · +10 more sites

RecruitingPhase 3NCT07225946

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Janssen Research & Development, LLC

Austin, TX · Dallas, TX · Houston, TX · +56 more sites

RecruitingNot applicableNCT07377006

Decision Support Tool to Enhance Germline Genetic Testing for Patients With Prostate Cancer

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 2NCT05489211

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Sponsor: AstraZeneca

Houston, TX · +17 more sites

RecruitingPhase 1 / Phase 2NCT07262619

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Sponsor: Eikon Therapeutics

Fort Worth, TX · Houston, TX · +8 more sites

RecruitingPhase 1NCT05983432

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Sponsor: SystImmune Inc.

Houston, TX · +20 more sites

RecruitingPhase 2NCT05011383

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Sponsor: VA Office of Research and Development

Houston, TX · +16 more sites

RecruitingPhase 1NCT07080242

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Sponsor: SystImmune Inc.

Dallas, TX · Houston, TX · +21 more sites

RecruitingPhase 1 / Phase 2NCT04969315

TT-4 and TT-10 as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors and Pleural Mesothelioma

Sponsor: Portage Biotech

Houston, TX · +1 more sites

RecruitingPhase 1NCT07493512

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

Sponsor: Amgen

Houston, TX · Irving, TX · +10 more sites

RecruitingPhase 1NCT06440005

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Sponsor: Angiex, Inc.

Houston, TX · San Antonio, TX · +5 more sites

RecruitingPhase 1NCT06458712

Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies

Sponsor: Duke Street Bio Ltd

Houston, TX · +3 more sites

RecruitingPhase 1NCT04221542

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Sponsor: Amgen

Houston, TX · Irving, TX · +23 more sites

RecruitingPhase 1 / Phase 2NCT06785636

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Sponsor: Pathos AI, Inc.

Dallas, TX · Houston, TX · +17 more sites

RecruitingPhase 2NCT06842498

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Sponsor: Kyntra Bio

Dallas, TX · Houston, TX · +21 more sites

RecruitingNot applicableNCT05043012

Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1NCT06242470

A Study of MGC026 in Participants With Advanced Solid Tumors

Sponsor: MacroGenics

Houston, TX · +5 more sites

RecruitingPhase not listedNCT05840484

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1 / Phase 2NCT06751329

A Study of DM002 in Patients With Advanced Solid Tumors

Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Houston, TX · +3 more sites

RecruitingPhase 1NCT06910657

IDOV-Immune for Advanced Solid Tumors

Sponsor: ViroMissile, Inc.

Houston, TX · San Antonio, TX · +1 more sites

RecruitingPhase 3NCT06274047

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

Sponsor: M.D. Anderson Cancer Center

Houston, TX · +5 more sites

RecruitingPhase 1 / Phase 2NCT06066437

NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 3NCT06592924

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Sponsor: Canadian Cancer Trials Group

Baytown, TX · Cypress, TX · Dallas, TX · +371 more sites

RecruitingPhase 1 / Phase 2NCT03972657

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Sponsor: Regeneron Pharmaceuticals

Houston, TX · +23 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.